BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 19242612)

  • 1. Genomic profiling of prostate cancers from African American men.
    Castro P; Creighton CJ; Ozen M; Berel D; Mims MP; Ittmann M
    Neoplasia; 2009 Mar; 11(3):305-12. PubMed ID: 19242612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct Genomic Alterations in Prostate Tumors Derived from African American Men.
    Liu W; Zheng SL; Na R; Wei L; Sun J; Gallagher J; Wei J; Resurreccion WK; Ernst S; Sfanos KS; Isaacs WB; Xu J
    Mol Cancer Res; 2020 Dec; 18(12):1815-1824. PubMed ID: 33115829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromosome 8 markers of metastatic prostate cancer in African American men: gain of the MIR151 gene and loss of the NKX3-1 gene.
    Barnabas N; Xu L; Savera A; Hou Z; Barrack ER
    Prostate; 2011 Jun; 71(8):857-71. PubMed ID: 21456068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel genomic alteration of LSAMP associates with aggressive prostate cancer in African American men.
    Petrovics G; Li H; Stümpel T; Tan SH; Young D; Katta S; Li Q; Ying K; Klocke B; Ravindranath L; Kohaar I; Chen Y; Ribli D; Grote K; Zou H; Cheng J; Dalgard CL; Zhang S; Csabai I; Kagan J; Takeda D; Loda M; Srivastava S; Scherf M; Seifert M; Gaiser T; McLeod DG; Szallasi Z; Ebner R; Werner T; Sesterhenn IA; Freedman M; Dobi A; Srivastava S
    EBioMedicine; 2015 Dec; 2(12):1957-64. PubMed ID: 26844274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Copy number and gene expression differences between African American and Caucasian American prostate cancer.
    Rose AE; Satagopan JM; Oddoux C; Zhou Q; Xu R; Olshen AB; Yu JZ; Dash A; Jean-Gilles J; Reuter V; Gerald WL; Lee P; Osman I
    J Transl Med; 2010 Jul; 8():70. PubMed ID: 20649978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the Prognostic Utility of the Cell Cycle Progression Score for Predicting Clinical Outcomes in African American and Non-African American Men with Localized Prostate Cancer.
    Canter DJ; Reid J; Latsis M; Variano M; Halat S; Rajamani S; Gurtner KE; Sangale Z; Brawer M; Stone S; Bardot S
    Eur Urol; 2019 Mar; 75(3):515-522. PubMed ID: 30391079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of a genetic variant in CYP3A4 on risk and clinical presentation of prostate cancer among white and African-American men.
    Bangsi D; Zhou J; Sun Y; Patel NP; Darga LL; Heilbrun LK; Powell IJ; Severson RK; Everson RB
    Urol Oncol; 2006; 24(1):21-7. PubMed ID: 16414488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and Functional Validation of Reciprocal microRNA-mRNA Pairings in African American Prostate Cancer Disparities.
    Wang BD; Ceniccola K; Yang Q; Andrawis R; Patel V; Ji Y; Rhim J; Olender J; Popratiloff A; Latham P; Lai Y; Patierno SR; Lee NH
    Clin Cancer Res; 2015 Nov; 21(21):4970-84. PubMed ID: 26089375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of germline copy number variation in high-risk African American families with prostate cancer.
    Ledet EM; Hu X; Sartor O; Rayford W; Li M; Mandal D
    Prostate; 2013 May; 73(6):614-23. PubMed ID: 23060098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced expression of SOS1 is detected in prostate cancer epithelial cells from African-American men.
    Timofeeva OA; Zhang X; Ressom HW; Varghese RS; Kallakury BV; Wang K; Ji Y; Cheema A; Jung M; Brown ML; Rhim JS; Dritschilo A
    Int J Oncol; 2009 Oct; 35(4):751-60. PubMed ID: 19724911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The E-cadherin -160 C/A polymorphism and prostate cancer risk in white and black American men.
    Pookot D; Li LC; Tabatabai ZL; Tanaka Y; Greene KL; Dahiya R
    J Urol; 2006 Aug; 176(2):793-6. PubMed ID: 16813949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate cancer risk allele specific for African descent associates with pathologic stage at prostatectomy.
    Whitman EJ; Pomerantz M; Chen Y; Chamberlin MM; Furusato B; Gao C; Ali A; Ravindranath L; Dobi A; Sesterhenn IA; McLeod DG; Srivastava S; Freedman M; Petrovics G
    Cancer Epidemiol Biomarkers Prev; 2010 Jan; 19(1):1-8. PubMed ID: 20056617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced mitochondrial DNA content associates with poor prognosis of prostate cancer in African American men.
    Koochekpour S; Marlowe T; Singh KK; Attwood K; Chandra D
    PLoS One; 2013; 8(9):e74688. PubMed ID: 24086362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Replication of prostate cancer risk loci on 8q24, 11q13, 17q12, 19q33, and Xp11 in African Americans.
    Hooker S; Hernandez W; Chen H; Robbins C; Torres JB; Ahaghotu C; Carpten J; Kittles RA
    Prostate; 2010 Feb; 70(3):270-5. PubMed ID: 19902474
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Faisal FA; Murali S; Kaur H; Vidotto T; Guedes LB; Salles DC; Kothari V; Tosoian JJ; Han S; Hovelson DH; Hu K; Spratt DE; Baras AS; Tomlins SA; Schaeffer EM; Lotan TL
    Clin Cancer Res; 2020 Jun; 26(11):2595-2602. PubMed ID: 31969336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic Profiling of Prostate Cancers from Men with African and European Ancestry.
    Koga Y; Song H; Chalmers ZR; Newberg J; Kim E; Carrot-Zhang J; Piou D; Polak P; Abdulkadir SA; Ziv E; Meyerson M; Frampton GM; Campbell JD; Huang FW
    Clin Cancer Res; 2020 Sep; 26(17):4651-4660. PubMed ID: 32651179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate cancer risk associated loci in African Americans.
    Xu J; Kibel AS; Hu JJ; Turner AR; Pruett K; Zheng SL; Sun J; Isaacs SD; Wiley KE; Kim ST; Hsu FC; Wu W; Torti FM; Walsh PC; Chang BL; Isaacs WB
    Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):2145-9. PubMed ID: 19549807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in clinical characteristics and disease-free survival for Latino, African American, and non-Latino white men with localized prostate cancer: data from CaPSURE.
    Latini DM; Elkin EP; Cooperberg MR; Sadetsky N; Duchane J; Carroll PR
    Cancer; 2006 Feb; 106(4):789-95. PubMed ID: 16400651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of germline mutations in African American and Caucasian men with metastatic prostate cancer.
    Ledet EM; Burgess EF; Sokolova AO; Jaeger EB; Hatton W; Moses M; Miller P; Cotogno P; Layton J; Barata P; Lewis BE; Nakazawa M; Zhu J; Dellinger B; Elrefai S; Nafissi NN; Egan JB; Shore N; McKay RR; Bryce AH; Cheng HH; Antonarakis ES; Sartor O
    Prostate; 2021 May; 81(7):433-439. PubMed ID: 33792945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Racial differences in serum prostate-specific antigen (PSA) doubling time, histopathological variables and long-term PSA recurrence between African-American and white American men undergoing radical prostatectomy for clinically localized prostate cancer.
    Tewari A; Horninger W; Badani KK; Hasan M; Coon S; Crawford ED; Gamito EJ; Wei J; Taub D; Montie J; Porter C; Divine GW; Bartsch G; Menon M
    BJU Int; 2005 Jul; 96(1):29-33. PubMed ID: 15963115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.